Ryo Hatano Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2016

Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryo Hatano Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 10/2004
5	Malignant Mesothelioma 01/2019 - 01/2014
3	Bronchiolitis Obliterans Syndrome 12/2022 - 04/2015
3	Immune System Diseases (Immune Disorders) 01/2019 - 02/2014
2	Leukemia 01/2023 - 12/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019 - 01/2019
2	Renal Insufficiency (Renal Failure) 01/2018 - 09/2004
2	Intrahepatic Cholestasis 01/2017 - 05/2015
2	Bronchiolitis 01/2016 - 04/2015
2	Fibrosis (Cirrhosis) 05/2015 - 04/2015
2	Inappropriate ADH Syndrome (SIADH) 01/2007 - 05/2005
2	Hyponatremia 01/2006 - 05/2005
1	Lung Injury 03/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024
1	Pulmonary Hypertension 01/2024
1	COVID-19 04/2023
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2023
1	Glomerulonephritis 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	Weight Loss (Weight Reduction) 12/2022
1	Hyperglycemia 10/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Inflammation (Inflammations) 01/2020
1	Ulcerative Colitis 01/2020
1	Obesity 09/2019
1	Rheumatic Diseases (Rheumatism) 09/2019
1	Erythema 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Nephrogenic Syndrome of Inappropriate Antidiuresis 01/2018
1	Pruritus (Itching) 06/2017
1	Mesothelioma 06/2016
1	Achlorhydria (Hypochlorhydria) 01/2016
1	Experimental Arthritis 07/2015
1	Arthritis (Polyarthritis) 05/2015
1	Lymphoma (Lymphomas) 05/2014

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 12/2022 - 07/2013
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 10/2010
3	CollagenIBA 01/2016 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 02/2014 - 05/2005
3	Aquaporin 2IBA 01/2007 - 05/2005
3	Vasopressins (Vasopressin)IBA 01/2007 - 05/2005
3	Aquaporins (Water Channels)IBA 01/2007 - 05/2005
2	indium-bleomycinIBA 01/2024 - 01/2023
2	Therapeutic UsesIBA 12/2022 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2014
2	Imiquimod (Aldara)FDA LinkGeneric 11/2019 - 01/2019
2	EnzymesIBA 06/2017 - 08/2015
2	ezrinIBA 01/2016 - 05/2015
2	Arginine Vasopressin (Argipressin)IBA 01/2007 - 05/2005
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2007 - 05/2005
1	LipopolysaccharidesIBA 03/2024
1	CytokinesIBA 03/2024
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2024
1	antiglomerular basement membrane antibodyIBA 04/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2023
1	AntibodiesIBA 04/2023
1	VaccinesIBA 04/2023
1	Immunoglobulin G (IgG)IBA 04/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Insulin (Novolin)FDA Link 10/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021
1	LecithinsIBA 10/2021
1	CyclodextrinsIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	LeptinIBA 09/2019
1	Peptides (Polypeptides)IBA 09/2019
1	Immune Checkpoint InhibitorsIBA 09/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 10/2018
1	podocalyxinIBA 01/2018
1	moesinIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017
1	Substance PIBA 06/2017
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	LipidsIBA 01/2016
1	RoxithromycinIBA 07/2015
1	Bile Acids and Salts (Bile Acids)IBA 05/2015
1	PeriostinIBA 05/2014
1	Transcription Factors (Transcription Factor)IBA 05/2014
1	Fibronectins (Fibronectin)IBA 02/2014
1	ParaffinIBA 02/2014

Therapy/Procedure

9	Therapeutics 01/2023 - 09/2004
1	Immunotherapy 09/2019
1	Cell Transplantation 01/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2015
1	Hematopoietic Stem Cell Transplantation 04/2015